Heart Failure
Conference Coverage
Angiotensin II may improve vasopressors’ efficacy
Adding a certain hormone could strengthen treatment options for vasodilatory shock patients.
Conference Coverage
Atrial fibrillation blunts beta-blockers for HFrEF
Do beta-blockers alter mortality in HFrEF with atrial fib??
News
FDA approves Sapien 3 transcatheter valve for bioprosthetic valve failure
Patients at high risk can now avoid open surgery when prosthetic valves fail.
Conference Coverage
A prescription for heart failure success: Change the name
PARIS – This condition’s very name dooms it to failure. Dr. Lynne Warner Stevenson has some ideas to fix that.
Conference Coverage
Spironolactone’s HFpEF benefit happens mostly in women
PARIS – What a new TOPCAT analysis reveals about sex differences in HFpEF
Feature
New heart failure guidelines prioritize prevention
The latest update to U.S. guidelines for heart failure management, released at the end of April , puts unprecedented emphasis on heart failure...
From the Journals
Oral iron of no benefit in heart failure with iron deficiency
High-dose oral iron therapy doesn’t improve exercise capacity in the estimated 50% of patients with symptomatic heart failure who also have iron...
Conference Coverage
PPIs triple heart failure hospitalization risk in atrial fib patients
PARIS – Atrial fib patients taking proton pump inhibitors, largely unnecessarily, have a far greater risk of hospitalization for an acute heart...
Conference Coverage
Bromocriptine shows efficacy, safety for peripartum cardiomyopathy
Now that the problem and treatment of peripartum cardiomyopathy have been studied, what are the next steps?
Conference Coverage
Noncardiovascular comorbidities spike in acute heart failure
PARIS – The biggest jump occurred in the prevalence of chronic obstructive pulmonary disease, which rose from 27% in 2005 to 35% in 2014.
Video
VIDEO: Setbacks of serelaxin, ularitide prompt rethinking acute heart failure strategies
PARIS – Experts offer lessons learned from the RELAX-AHF-2 and TRUE-AHF trials.